Kura Oncology
KURA
#5933
Rank
โ‚ฌ0.86 B
Marketcap
10,00ย โ‚ฌ
Share price
-2.59%
Change (1 day)
0.30%
Change (1 year)

Revenue for Kura Oncology (KURA)

Revenue in 2025 (TTM): โ‚ฌ95.47 Million

According to Kura Oncology 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ89.34 Million. In 2024 the company made a revenue of โ‚ฌ51.77 Million an increase over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Kura Oncology from 2015 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ95.47 M84.38%
2024 โ‚ฌ51.77 M
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA